Currently Browsing
Our Products
Aurobindo Receives FDA Approval for Niacin Extended-Release Tablets USP
Overview
- Reference Brand:
- Therapeutic Class:
Specifications
Order Information
Attributes
- Physical Form:
October 02, 2026 | Aurobindo Receives FDA Approval for Perampanel Tablets, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, and 12 mg ... Read more
September 25, 2026 | Aurobindo Receives FDA Approval for Metronidazole Vaginal Gel, 0.75% ... Read more
September 17, 2026 | Aurobindo Receives FDA Approval for Cyclosporine Capsules USP (Modified) (Soft Gelatin Capsules), 25 mg, 50 mg, and 100 mg ... Read more